<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[45, 55] powder extract of house dust mite (HDM),<br>[92, 94] placebo,<br>[101, 102] PI<br>[103, 106] inhalation of lactose<br>[120, 125] disodium cromoglycate (DSCG)<br></td>
<td width=33%>
[0, 2] Local immunotherapy<br>[36, 55] local immunotherapy (LI) by inhalation of a powder extract of house dust mite (HDM),<br>[58, 63] parenteral immunotherapy (PI)<br>[87, 88] LI<br>[92, 110] placebo, 5 patients (Group B) underwent PI and inhalation of lactose for 6 months.<br>[120, 125] disodium cromoglycate (DSCG)<br></td>
<td width=33%>
[0, 8] Local immunotherapy by inhalation of a powder extract<br>[12, 18] house dust mite Dermatophagoides pteronyssinus:<br>[24, 27] parenteral immunotherapy.<br>[36, 55] local immunotherapy (LI) by inhalation of a powder extract of house dust mite (HDM),<br>[58, 66] parenteral immunotherapy (PI) by injection,<br>[86, 110] underwent LI and subcutaneous injections of placebo, 5 patients (Group B) underwent PI and inhalation of lactose for 6 months.<br>[111, 130] both groups each inhalation was preceded by premedication with disodium cromoglycate (DSCG) (40 mg).<br>[230, 231] LI<br>[235, 237] PI,<br>[254, 255] LI<br>[261, 262] DSCG<br>[266, 269] therapeutic inhalation,<br></td>
</tr>
